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Abstract
Background: While one in ten Australians suffer from chronic low back pain this condition
remains extremely difficult to treat. Many contemporary treatments are of unknown value. One
potentially useful therapy is the use of motor control exercise. This therapy has a biologically
plausible effect, is readily available in primary care and it is of modest cost. However, to date, the
efficacy of motor control exercise has not been established.
Methods: This paper describes the protocol for a clinical trial comparing the effects of motor
control exercise versus placebo in the treatment of chronic non-specific low back pain. One
hundred and fifty-four participants will be randomly allocated to receive an 8-week program of
motor control exercise or placebo (detuned short wave and detuned ultrasound). Measures of
outcomes will be obtained at follow-up appointments at 2, 6 and 12 months after randomisation.
The primary outcomes are: pain, global perceived effect and patient-generated measure of disability
at 2 months and recurrence at 12 months.
Discussion: This trial will be the first placebo-controlled trial of motor control exercise. The
results will inform best practice for treating chronic low back pain and prevent its occurrence.
Background
The problem of chronic low back pain
Low back pain is the main cause of work absence and dis-
ability in industrialised societies. Approximately 10–20%
of patients with low back pain develop chronic pain,
defined as pain persisting for more than 3 months. Addi-
tional to their pain these patient's health problems typi-
cally include reduced physical function and psychological
distress[1]. These patients use more than 80% of health
care resources for back problems, and treatment has a low
success rate [2].
In 2002, arthritis and musculoskeletal disorders were
announced as the new National Health Priority Area in
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recognition of the major health and economic burden
that these diseases place on the Australian community [3].
Amongst this group of diseases back pain is both the most
prevalent and most costly single disease [4]. The 2001
National Health Survey revealed that chronic back pain is
the most prevalent illness from the seven National Health
Priority Areas [5].
The severity of chronic pain can be described with four
hierarchical grades, Grades I–IV, that consider the pain
intensity and the degree of disability associated with the
pain [6]. An Australian population-based survey, noted
that 22% of respondents reported chronic pain with 39%
of respondents classed as Grade I (least severe), 35% as
Grade II, 14% as Grade III and 13% as Grade IV (most
severe) [7]. The most common cause of chronic pain was
low back pain (45% of cases).
Effectiveness of treatments for chronic low back pain
While there are a myriad of treatment options for chronic
low back pain, there is only one clinical practice guideline
for chronic non-specific low back pain: The European
Guideline[8]. This guideline and the relevant Cochrane
reviews [9] provide the most reliable sources of evidence
on treatment for this condition. Unfortunately the
Cochrane reviews provide fairly bleak reading for both cli-
nicians and patients. Most of the reviews (7/13) con-
cluded that the treatment under review was of unknown
value. Five of the thirteen reviews concluded that there
was some evidence for the treatment under review how-
ever significant limitations for each treatment were noted.
These limitations included: no long term effect (e.g. back
school); serious side effects (e.g. muscle relaxants); small
effect size (e.g. massage); treatment improves outcomes
other than pain (e.g. work conditioning) and no informa-
tion available on patient or dose selection (e.g. behav-
ioural treatment). The European Guideline produced
similar conclusions [8]. In only one Cochrane review, the
review of multidisciplinary rehabilitation/functional res-
toration, did the reviewers conclude that there was strong
evidence for the therapy. However the reviewers also
noted that these programs were only effective when they
included >100 hours of therapy. Because these programs
are multidisciplinary they are typically provided in a terti-
ary setting and because of the amount of time involved
they are also very expensive. Accordingly functional resto-
ration is usually reserved for the most severe cases of
chronic low back pain.
The majority of patients with chronic low back pain has
less severe pain (i.e. Grades I–III) and are typically man-
aged in primary care. Not surprisingly clinicians find man-
aging chronic low back pain difficult with qualitative
research reporting that therapists' inability to identify
effective treatment choices for their patients makes them
state clinicians perhaps feel 'helpless' 'disillusioned' and
'pessimistic' [10]. Studies of patients reveal similar nega-
tive feelings and emotions [11].
To address this major problem, we plan to begin a coordi-
nated program of research in which treatments that seem
most promising are rigorously evaluated in randomised
controlled trials. We define 'most promising treatments'
as those that (i) appear to have clinically important effects
that are maintained in the long term, (ii) are readily avail-
able and of modest cost and (iii) there is biological plau-
sibility for the effect. Exercise therapy is our first candidate
for evaluation in this program of research because it satis-
fies each of these three criteria, however at present trials
have reported conflicting results.
While some trials of exercise therapy have reported large,
durable and clinically important effects of treatment
[12,13] others have not [14]. The uncertainty is reflected
in the conclusion of the Cochrane review of exercise ther-
apy: '...there is conflicting evidence on the effectiveness of
exercise therapy...' [15]
Many factors are likely to have contributed to the incon-
sistent results across trials. Importantly, interpretation of
the results of exercise trials is difficult because most trials
have been pragmatic trials, comparing two active treat-
ments delivered in routine practice (e.g. exercise vs. usual
medical care [12];  exercise  vs.  physiotherapy  [16]) These
comparisons cannot provide a clear estimate of the effects
of exercise treatment because most of the comparison
treatments are also of unknown efficacy. Secondly, there
has been insufficient appreciation by researchers conduct-
ing trials and by reviewers summarising trials of the wide
variety of forms exercise can take and also trials do not
control the quality of exercise intervention. While exercise
is typically regarded as a single class of treatment we
believe that this level of conception is inappropriate and
analogous to not distinguishing between different classes
and doses of drugs when prescribing medication. The
types of exercise programs for chronic low back pain vary
widely from land-based exercise versus exercise in water to
isolated trunk exercise versus a walking program and it is
unlikely that all programs are equally effective for all
patients. Lastly, methodological quality varies greatly
across previous exercise trials, for example in the
Cochrane review [15] the least sound trial attended to
none of the nine methodological criteria while the best
attended to seven of the nine. Because methodological
quality has been shown to affect the results of trials in
other areas of health care [17] it is likely that a lack of rigor
has contributed to the inconsistent results.
It is not sensible to talk about evaluating the efficacy of
exercise without specifying the type of exercise. We haveBMC Musculoskeletal Disorders 2005, 6:54 http://www.biomedcentral.com/1471-2474/6/54
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chosen to measure the efficacy of motor control exercise
(sometimes called specific spinal stabilisation exercise)
for chronic low back pain, rather than other forms of exer-
cise, because it is a widely used form of exercise and there
is an extensive body of literature that provides a rationale
for the mechanism of action. The only way to clearly
establish the value of motor control exercise in the man-
agement of chronic low back pain is to evaluate the effi-
cacy of this form of exercise therapy in a methodologically
sound randomised placebo-controlled trial. Prior to con-
ducting a placebo-controlled trial of exercise we felt that it
was prudent to identify the most promising form of exer-
cise that would subsequently be evaluated in the placebo-
controlled trial. To do this we conducted a randomised
controlled trial where 160 patients were randomised to an
8 week program of either motor control exercise or gen-
eral exercise[18].
The trial demonstrated that both programs were accompa-
nied by large improvements in pain and disability. Motor
control exercise produced significantly better outcomes in
the short term, and there was a trend for motor control
exercise to produce better outcomes at 6 month follow-
up. Accordingly we have chosen to evaluate motor control
exercise in the proposed trial. Our choice coincides with
the research agenda set by the 2004 European Guideline:
"The effectiveness of specific types of exercise therapy
needs to be further evaluated. This includes the evaluation
of spinal stabilisation exercises..." [8] p 7.
Motor control exercise: treatment rationale
The use of motor control exercise is based on research that
has shown that:
(i) People with low back pain have changes in the strategy
for control of the trunk muscles in that activity of the deep
muscles is impaired (delayed, less tonic) and these mus-
cles are atrophied[19,20].
(ii) Although all muscles contribute to control of move-
ment and stability of the spine, the deep muscles have a
critical role for control of intervertebral motion [21-25],
but with the potential advantage of allowing dynamic
control of the spine.
(iii) Evidence that people with back pain tend to adopt a
strategy for increased stiffness and stability at the expense
of spinal function [26].
(iv) Non-resolution of changes in the deep muscle system
is linked to recurrences of low back pain [27].
The evidence above underpins the primary aim of motor
control exercise, which is to re-establish normal control of
the deep spinal muscles, reducing the activity of more
superficial muscles that tend to stiffen the spine and have
increased activity in low back pain, and then maintain
normal control during progressively more demanding
physical and functional tasks[28].
The key feature of the motor control exercise approach is
the training of the deep trunk muscles in isolation before
progressing to demanding tasks that train coordination of
the deep and the superficial trunk muscles [28]. However,
unlike functional restoration approaches, training the
deep trunk muscles in isolation from the superficial trunk
muscles is difficult. In order to teach patients how to con-
tract the deep muscles of the spine, in addition to clinical
skills of palpation and observation [29] physiotherapists
need to use technical devices such as pressure monitors,
electromyography and ultrasound imaging to provide
feedback to the patient.
The premise of the motor control approach is that simple
functional exercise alone does not re-establish coordina-
tion of the trunk muscles. This premise is supported by
the finding that the adaptation of these muscles to pain is
still present following recovery from an episode of low
back pain, when patients have returned to normal func-
tional levels [19,20]. Furthermore, recent data confirm
that coordination of the abdominal muscles can be
restored with training of specific activation of the trunk
muscles, but not a simple activation during a sit up task
[30]. Notably, non-resolution of muscle dysfunction is
associated with increased back pain recurrence [27]. Also,
asymptomatic people with normal activity levels who are
unable to perform a task that is thought to reflect volun-
tary activation of the deep trunk muscles, are ~6 times
more likely to develop back pain than asymptomatic peo-
ple who are able to perform the same task [31].
Motor control exercise: level I and II evidence
At present there is no evidence for the efficacy of motor
control exercise in the treatment of chronic low back pain.
No systematic review of motor control exercise has been
published, although one is being completed by our group.
While the majority of trials (5 of 8) report that motor con-
trol exercise is effective in the management of chronic or
recurrent low back pain most (7 of 8) have permitted co-
intervention so that the contribution of motor control
exercise is unclear. Additionally, all of these previous trials
have used other treatments of unknown efficacy as the
comparison intervention and so treatment efficacy cannot
be measured. For example the earliest trial [12] reported
that motor control exercise is more effective than usual
medical care however this result provides an ambiguous
estimate of treatment effectiveness because other trials
have reported that sham physiotherapy treatments are
more effective than usual medical care [32].BMC Musculoskeletal Disorders 2005, 6:54 http://www.biomedcentral.com/1471-2474/6/54
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We will evaluate the efficacy of motor control exercise in
a placebo-controlled randomised controlled trial. The
results of our study will be invaluable for more efficacious
evidence-based management of patients with non-specific
chronic low back pain. Once efficacy is established, we
will be able to progress to measuring whether there are
additive or multiplicative effects of other treatments that
are commonly administered as co-interventions with
motor control exercise and thus to being able to make
valid recommendations for their use.
Methods
Overview of research design
The study will be a randomised, blinded, placebo-control-
led trial of a motor control exercise program for patients
with chronic low back pain. The exercise program will
consist of 12 individually supervised half-hour sessions
over an 8-week period with treatment outcomes measured
at 2 months, 6 months and one year.
Hypotheses
(i) An 8-week motor control exercise program designed to
restore control of the trunk muscles improves pain, disa-
bility and global perceived effect in participants with
chronic low back pain at 2 months follow-up.
(ii) The improvements in pain, disability and global per-
ceived effect following motor control exercise are main-
tained at 6 and 12 months follow-up.
(iii) At 12 month follow up recurrence is less in the motor
control exercise group.
Subject recruitment
A total of 154 participants will be recruited into the study.
Participants will be screened for suitability for motor con-
trol exercise according to usual clinical practice. The
screening instruments identify participants who are
unsuitable for exercise management of their low back
pain because of significant co- morbidity (serious spinal
pathology, contraindication to exercise). A clinical assess-
ment will identify patients who we expect would best be
managed by a motor control exercise program rather than
some other form of exercise or physiotherapy manage-
ment.
Screening
To screen for serious pathology, the physiotherapist will
conduct a diagnostic triage [33]. Participants in whom
serious spinal pathology is suspected will be excluded
from the trial and referred to their medical practitioner for
review. Potential participants will be screened for con-
traindications to exercise using the Physical Activity Read-
iness Questionnaire [34]. If a volunteer provides a
positive response to items 1, 2, 3, 4, 6 or 7, the trial phys-
iotherapist will discuss the case with the referring medical
practitioner and if necessary a medical review will be
undertaken to exclude any contraindication to exercise as
listed in the ACSM guidelines [34].
The clinical assessment used to ensure that the motor con-
trol approach is indicated is based on the key text [28] and
is a normal part of clinical assessment of low back pain.
The assessment involves evaluation of the motor control
strategy during a specific trunk muscle task – drawing in
of the lower abdomen while maintaining an isometric
contraction of the medial back muscles. The following cri-
teria constitute correct performance of the task:
1. Moderate and sustained activation (> 10 seconds) of
transversus abdominis
2. Moderate and sustained activation (> 10 seconds) of
the lumbar multifidus muscles
3. Little or no activation of the global trunk muscles
4. No spinal or rib cage movement.
5. Normal breathing
Evaluation of task performance including satisfaction of
the above criteria is dependent on the clinical skills of the
physiotherapist. Patients who are unable to perform this
task correctly will be considered suitable for motor con-
trol exercise.
Participants will be included if they meet all of the follow-
ing inclusion criteria:
• Non-specific low back pain +/- leg pain of at least 3
months duration
• Currently seeking care for low back pain
• Aged greater than 18 and less than 80 years
• Comprehends English
• Clinical assessment indicates that the subject is suitable
for motor control exercise
• Expects to continue residing in SWSAH region for study
duration.
Participants will be excluded if they have any of the fol-
lowing:
• Suspected or confirmed serious spinal pathology (frac-
ture, metastatic, inflammatory or infective diseases of theBMC Musculoskeletal Disorders 2005, 6:54 http://www.biomedcentral.com/1471-2474/6/54
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spine, cauda equina syndrome/widespread neurological
disorder)
• Suspected or confirmed pregnancy
• Unable to speak English
• Nerve root compromise (2 of strength, reflex or sensa-
tion affected for same nerve root)
• Spinal surgery
• Scheduled for major surgery during treatment or follow-
up period
• Any of the contraindications to exercise listed on page
42 of the ACSM guidelines [34]
• Any contraindication to pulsed ultrasound or pulsed
shortwave.
Specific spinal pathology or contraindication to treatment
may be suspected based on the results of the screening
questionnaire and the Physical Activity Readiness Ques-
tionnaire. If the assessor suspects the presence of any
pathology or contraindication to treatment, these subjects
should be further investigated and medical clearance
obtained, if necessary.
Assessment and allocation
Outcome measures
Measures of outcomes will be obtained at follow-up
appointments at 2, 6 and 12 months after randomisation.
To maximise attendance at these follow-ups, appoint-
ments will be made by phone and then a letter will be sent
confirming appointment and a reminder phone call will
be made 24 hrs before the appointment. Every attempt
(within ethical constraints) will be made to obtain out-
come data, regardless of subject's compliance with trial
protocols. Follow-up measures will be scored by an inves-
tigator who is blinded to group allocation. At 2 months,
information about side effects of treatment will be col-
lected from all participants using open-ended question-
ing.
Following the screening consultation, personal character-
istics (age, gender, ethnicity, religion, weight, height, level
of education, employment status, doctor's details and
contact information) and information about symptoms
of low back pain will be collected (eg DASS 21 [35];
Chronic Pain Grade Questionnaire) The following treat-
ment efficacy variables will be measured at baseline, 2, 6
and 12 months.
1. Average pain intensity over last week (0–10 scale) [36-
38]
2. Patient-generated measure of disability (Patient-Spe-
cific Functional Scale) [36-38]
3. Global perceived effect (Global Perceived Effect Scale)
[36-38]
4. Condition-specific measure of disability (Roland Mor-
ris Disability Questionnaire) [36-38]
5. Recurrence at 12 months
The primary outcomes are pain, GPE and PSFS at 2
months and recurrence at 12 months.
Randomisation
Participants will be allocated to treatment group using
sealed opaque envelopes. The allocation sequence will be
generated by author CM. Participants will be scheduled to
receive their first treatment within one week of randomi-
sation.
Interventions
Contemporary physiotherapy practice in exercise prescrip-
tion is to assess each patient and to implement the form
of exercise that is most relevant to the particular clinical
presentation. At present this widely accepted approach
relies primarily upon the clinical expertise of the therapist.
We have elected to evaluate motor control exercise deliv-
ered in this manner because this approach is regarded as
contemporary best practice.
Participants in each group will receive 12 half hour treat-
ments over an 8-week period, i.e. 2 sessions/week in the
first month and 1 session/week in the second month. The
treatment sessions are designed to become less frequent
over time to encourage independence and continuation of
exercise when therapy is complete. This is consistent with
current clinical practice.
The motor control exercise program is based on the treat-
ment approach reported by O'Sullivan et al [12], Richard-
son et al [28], and Moseley [39]. A brief description is
provided below.
At the first session, participants will be comprehensively
assessed and then will be prescribed exercises aimed at
improving function of specific muscles of the low back
region to be conducted in sessions 2–11. Stage 1 involves
the most commonly prescribed exercise aimed at retrain-
ing multifidus (a back muscle) and transversus abdomi-
nus (a deep abdominal muscle); these exercises will be
supplemented with exercises for the pelvic floor muscles,BMC Musculoskeletal Disorders 2005, 6:54 http://www.biomedcentral.com/1471-2474/6/54
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breathing control and control of spinal posture. Partici-
pants will be taught how to contract these muscles inde-
pendently from the superficial trunk muscles [28,40].
Physiotherapists will use real-time ultrasound biofeed-
back to enhance learning of the tasks. When participants
are able to perform these exercises, they will be gradually
upgraded until the patient is able to maintain isolated
contractions of these muscles for 10 seconds, up to a max-
imum of 10 repetitions, during normal respiration [28].
When this level of competence has been achieved,
patients will be considered ready to progress to Stage 2.
Stage 2 of the approach involves increasing the complex-
ity of the exercise by progressing through a range of func-
tional tasks and exercises targeting coordination of trunk
and limb movement and maintenance of trunk stability.
The range and progression of exercises is well set-out in
clinical texts [28] and is individualised to the patient
based on this presentation. Participants require the ongo-
ing support of a trained physiotherapist to ensure correct
performance of the exercises. Session 12 is a discharge ses-
sion where the patient's progress will be reviewed and
patients will be prescribed exercises to continue at home.
The placebo intervention is 20 minutes of detuned short
wave diathermy and 5 minutes of detuned ultrasound for
12 sessions over an eight week period. This attention con-
trol will be used because there is no known treatment
effect from the detuned machines, but it has been estab-
lished in previous trials (including one of our own [37])
that participants view this as a credible treatment. To
increase the perceived credibility of the attention control,
participants will undergo an examination including rou-
tine screening for contraindications at the first consulta-
tion and the normal clinical reassessment that would
occur with the active forms of these interventions at each
subsequent treatment. Each placebo treatment session
will be 30 minutes in duration to match the active treat-
ment sessions.
Participants in both treatment groups will be asked not to
seek other treatments for their chronic low back pain and
where possible not to change current medications during
the treatment period. Several mechanisms will be used to
ensure that the trial protocol is consistently applied. Pro-
tocol manuals will be developed and staff will be trained
to ensure that screening, assessment, randomisation and
treatment procedures are conducted according to proto-
col. To ensure standardisation across sites we will hold
regular meetings with site visits and teleconferencing. An
independent researcher will monitor a randomly chosen
subset to ensure adherence to assessment, randomisation
and treatment procedures.
If a participant is concerned about his or her condition
during the study, the physiotherapist will screen for
potentially serious pathology and, where appropriate,
refer the patient to a medical practitioner. The medical
practitioner will be asked not to request the participant's
group allocation unless it is deemed necessary for medical
care. At the completion of the exercise program, patients
will be encouraged to continue the home exercise routine
demonstrated at the discharge session. Participants will be
free to seek other treatment after the experimental period.
After the first treatment session the patient will complete
a treatment credibility scale [41]. At the 8 week follow-up
information about side-effects of treatment will be col-
lected using open-ended questioning. At the 12 month
follow-up the participants will be asked to rate the help-
fulness, understanding and friendliness of therapist and
helpfulness of treatment and to nominate which treat-
ment they thought they received. Additionally informa-
tion about other treatment received for their low back
pain during the study period will be sought using open-
ended questioning.
Data integrity
The integrity of trial data will be monitored by regularly
scrutinising data sheets for omissions and errors. Data will
be double entered and the source of any inconsistencies
will be explored and resolved.
Data analysis
Treatment efficacy
In our primary analysis, we will use a regression model to
test for the effect of treatment on outcome at 2, 6 and 12
months follow-up with the baseline value of the outcome
entered as a covariate. A treatment effect size will be calcu-
lated for each of the follow-up time points and, if there is
a statistically significant treatment effect at any time point,
we will also calculate number needed to treat (NNT) to
achieve pain recovery (pain < 1 out of 10: [42]) and 95%
CI. The recurrence outcome will be analysed with logistic
regression.
Predictor of response to treatment
We will include an interaction term baseline DASS-21
depression score × group to the regression analysis to see
if the effect of motor control exercise is influenced by the
baseline DASS-21 depression score.
Sample size calculations
We have designed the study to detect a clinically impor-
tant difference of 1 unit on the 0–10 pain intensity scale
(estimate for SD = 2.00), 1 unit on the 0–10 patient spe-
cific functional scale (estimate for SD = 1.8); 1 unit on the
0–10 Global Perceived Effect Scale (estimate for SD =
1.65) and 4 units on the 24 item Roland Morris DisabilityBMC Musculoskeletal Disorders 2005, 6:54 http://www.biomedcentral.com/1471-2474/6/54
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Questionnaire (estimate for SD = 4.9). We have taken the
SD estimates from a trial we completed that recruited a
similar patient cohort[37] With specifications of alpha =
0.05, power = 0.80 a sample size of 77 participants per
group is required to detect an effect size of 0.50 SD (the
smallest effect size we have specified for the four out-
comes). Based on the results of the same trial [37] we have
allowed for 15% non-compliance with treatment, 15%
loss to follow-up, and assumed a correlation between
baseline and change scores of outcomes of 0.5. Accord-
ingly we will recruit 77 participants per group or 154 par-
ticipants in total.
Justification of study design
Placebo
Designing an appropriate placebo treatment that mimics
a physiotherapy exercise program is challenging. The
sham interventions used in previous exercise trials do not
satisfy the criteria of being both inert (e.g. the use of hot
packs) and credible (e.g. allocation to a treatment waiting
list). Accordingly, we will use sham electrotherapy as a
control. This sham is clearly inert and is regarded as a cred-
ible treatment by participants. [37] To ensure that partici-
pants remain unaware of study group, it is necessary to
carefully describe the study to patients. In the previous
trial where we used sham electrotherapy as a control for
exercise, we used the following description:
'In this trial normal physiotherapy treatment and placebo phys-
iotherapy treatment will be provided. A placebo treatment is a
harmless treatment delivered at less than the effective dose. We
will not tell you which type of treatment you will receive and it
is unlikely that you could distinguish them.'
Trial staff described the placebo intervention as 'pulsed
ultrasound' and 'pulsed shortwave' and explained to
patients that they would probably not feel any sensation
during treatment.
Controlling bias
The trial has been designed to include key methodological
features that have been recognised as minimising bias in
clinical trials. These features include: true randomisation,
concealed allocation, specification of eligibility criteria,
blind outcome assessment, patient blinding, blind analy-
sis and intention-to-treat analysis. The nature of the treat-
ments precludes blinding of treatment provider. Trial staff
will be trained to ensure consistency of screening, assess-
ment, randomisation and treatment procedures. Partici-
pant's perception of the credibility of treatment will be
determined after the first treatment [41]; and at the com-
pletion of treatment both assessors and participants will
be asked to identify what treatment they think the partic-
ipant received.
Outcomes
Measures of pain symptoms, disability and generic health
status will be taken from the 'core set' of outcome meas-
ures for clinical research recently advocated by an interna-
tional panel of back pain researchers [43]. The panel
considered factors such as reliability, validity and respon-
siveness before recommending a measure. We have sup-
plemented the back-related disability measure advocated
in the core set (Roland Morris) with a patient-generated
measure of disability (Patient-Specific Functional Scale)
because there is evidence that patient-generated measures
of disability are more responsive than condition-specific
measures [37,44].
Conclusion
We have presented the rationale and design of a rand-
omized controlled clinical trial evaluating the effect of
motor control exercise versus placebo in patients with
chronic LBP. The results of this trial will be published as
soon as they are available.
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